Picture of Sabien Technology logo

SNT Sabien Technology News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapMomentum Trap

REG - Sabien Technology - Half-year Report for the 6 months to 31 Dec 2023

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240219:nRSS5882Da&default-theme=true

RNS Number : 5882D  Sabien Technology Group PLC  19 February 2024

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION
11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

19 February 2024

Sabien Technology Group Plc

("Sabien", the "Company" or the "Group")

 

Unaudited Interim Results for the six months ended 31 December 2023

 

Sabien Technology Group plc (AIM: SNT), the company focused on a green
aggregation strategy, today announces its unaudited interim results for the
six-month period ended 31 December 2023 (the "Period"). Comparative figures
are shown for the comparable period in the previous financial year unless
otherwise stated:

 

Financial highlights

 

                                6 months to 31 December 2023  6 months to 31 December 2022  Year to

                                                                                            30 June

                                                                                            2023
                                Unaudited                     Unaudited                     Audited

 Sales revenue          £'000   369                           238                           1,098

 Sales orders received  £'000   386                           212                           1,136

 Sales invoices raised  £'000   320                           189                           1,118

 Gross profit margin    %       62                            51                            64

 Net loss after tax     £'000   (371)                         (437)                         (702)

 Cash at end of period  £'000   176                           354                           436

 

Executive Chairman's Statement

It is very pleasing to report interim results which so clearly demonstrate
progress. Revenue growth of 55% highlights the success of M2G in both raising
awareness and innovating within its core product suite. That this translated
into an 88.4% improvement in gross profit validates this strategy. The 82%
increase in orders received underpins my confidence in further growth.

 

This confidence extends to the development of b.grn. Our recent progress in
the US has brought the generation of a positive return much closer. Like M2G
before it, b.grn's concept requires wider awareness of the benefits in order
to secure its growth. I am in no doubt that such awareness is more likely to
be achieved within US markets and that US awareness will drive adoption in
Europe.

 

 

M2G Business

M2G has continued to outperform its KPIs through the first half of the current
financial year. Specifically, it has achieved significant progress in raising
awareness of its products' benefits within a disparate range of customers. The
consequent growth in sales, billings, and orders is a testament to both M2G's
concept and its ability to innovate within this space.

 

M2G Cloud Connect has assisted customers in saving 1.41 million KgCO(2) in
just one year. As Cloud Connect is rolled out to US markets, it is expected
that these savings will increase further. M2G Evo is in the final stages of
development and is on the verge of CE and UL testing, the successful
conclusion of which will allow a wide launch.  In addition, M2G Evo will
allow Sabien to access additional supply chains due to the use of common
components. This should reduce the cost of the product, thereby increasing
gross margin.

 

For the six months ended 31 December 2023, Sabien recognised M2G revenue of
£0.37m, an increase of over 1.5x on the comparative period (£0.24m).  To 16
February 2024, Sabien has received orders in excess of £0.50m, an increase of
over 2x on the comparative period (£0.25m); and has invoiced £0.35m, an
increase of over 1.3x  on the prior year (£0.27m).  Recent orders include
an order from a new channel partner of £0.07m.

 

COF / b.grn Business

Sabien confirms that its affiliate company, b.grn Group Limited ("b.grn"), is
participating in a consortium of green energy and sustainability companies to
establish a resource cluster within a large, fast growing, environmentally
conscious, US city (the "City") which has approved this announcement. A
Mayor-led initiative established a global competition process more than two
years ago, and the successful responding group was selected in late December
2023. Under this initiative, through an agreement with the project
developer, b.grn will have the potential to construct and operate the first
US-based installation of COF technology on a site leased from the City. The
installation will process plastic waste both provided by the City and sourced
from private enterprises. b.grn envisions that the offtake products from the
proposed plant will be consumed within the City.

 

It is anticipated that this project, which is expected to be announced by the
City no later than Q3 of 2024, will attract significant funding and will be a
blueprint for wider technology adoption in the US and internationally. Under
existing contracts, Sabien will benefit for both sales commissions on the
supply of equipment to the project and a share of operational profits
generated by b.grn.

 

To drive the successful launch of this project the services of a circular
economy industry leader and former public company CEO have been secured to
lead negotiations with the City. An LOI/MOU detailing high level business
terms between the City, b.grn and other consortium members is likely to be
signed and announced in the next Quarter with an established contract or
contracts to be signed and announced no later than Q4 2024. It is likely
Sabien will need to invest in the initial administrative enablement of this
project to ensure the necessary external development funding is secured.

 

Proton Technologies Canada Inc. and Aeristech investment

Sabien is not focusing on these partners currently and there is no further
update since the 2023 annual report.

 

 

Parris Group Loan

Sabien currently has a funding requirement to bridge the timing of the
significant M2G order conversion into revenue, as well as requirements to
complete the M2G Evo development and continue with the COF/b.grn project.

 

To fund this requirement, my family company, Parris Group Limited ("PGL"), has
made a £0.2m debt facility available to Sabien.

 

The loan facility (the "New Loan") follows a previous PGL 12-month
arrangement, announced in March 2022, for £209,302.33, of which £5,135
including accrued interest remained outstanding as at 31 December 2023.

 

The key terms of the New Loan are as follows:

 

·    Up to £200,000;

·    Interest rate of 12% per annum;

·    Interest payable quarterly;

·    Repayable by agreement with the Sabien board of directors for an
initial period of 12 months unless replaced by another debt facility,
afterwards on demand; and

·    Unsecured.

 

Summary

Against a turbulent background, Sabien has made considerable positive progress
in the first half of the current financial year. It has delivered and
developed such that further progress is more likely.

 

M2G has exceeded expectations; generating revenue at lower cost, winning
orders across geographies, and innovating within its product suite. b.grn has
achieved another milestone in its development trajectory. The expected signing
of terms with a US city will bring revenue generation closer and provide a
high-profile platform from which to raise awareness and adoption elsewhere.

 

I have argued that Sabien's development will not be linear. I remain of this
view, but I am now more confident that our businesses' growth prospects are
not dependent on the economic environment. Our challenge is to raise awareness
and having done so, to deploy successfully.

 

The scale and scope of our development is in our hands. I believe that we have
demonstrated this ability in our first half results. I am confident that it
will remain the case and that further growth is in prospect.

 

 Richard Parris

 Executive Chairman
 19 February 2024

 Related Party Transaction

 Parris Group Ltd is a Company controlled by Richard Parris, the Executive
 Chairman of the Company, and his family.  The Board, other than Mr Parris,
 considers, having consulted with Allenby Capital Limited, the Company's
 nominated adviser, that the terms of the New Loan are fair and reasonable
 insofar as its shareholders are concerned.

 
 

 For further information:                          +44 20 7993 3700

                                                   Scott.fulton@sabien.com (mailto:Scott.fulton@sabien.com)

 Sabien Technology Group plc

 Richard Parris, Executive Chairman

 Scott Fulton, Investor Relations

 Allenby Capital Limited (Nominated Adviser)

 John Depasquale / Nick Harriss / Vivek Bhardwaj   +44 203 328 5656

 Peterhouse Capital Limited (Broker)               +44 207 469 0930

 Duncan Vasey / Lucy Williams

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Statement of Comprehensive Income for the period
ended 31 December 2023

 

                                                                           Notes  6 months to 31 December 2023  6 months to 31 December 2022  Year to

                                                                                                                                              30

                                                                                                                                              June

                                                                                                                                              2023
                                                                                  Unaudited                     Unaudited                     Audited
                                                                                  £'000                         £'000                         £'000

 Revenue                                                                          369                           238                           1,098
 Cost of Sales                                                                    (141)                         (117)                         (394)

 Gross Profit                                                                     228                           121                           704

 Administrative expenses                                                          (597)                         (676)                         (1,331)

 Exceptional item                                                                 -                             -                             -

 Operating loss                                                                   (369)                         (555)                         (627)

 Other income                                                                     -                             100                           1

 Finance cost                                                                     (4)                           (3)                           (7)
 Finance income                                                                   2                             -                             3
 Impairment loss                                                                  -                             -                             (99)

 Loss before tax                                                                  (371)                         (458)                         (729)

 Tax credit                                                                       -                             21                            27

 Loss for the period attributable to equity holders of the parent company         (371)                         (437)                         (702)

 Other comprehensive income for the period                                        -                             -                             -
                                                                                  (371)                         (437)                         (702)

 Total comprehensive income for the period

 Loss per share in pence - basic                                           3      (1.71)p                       (2.12)p                       (3.59)p
 Loss per share in pence - diluted                                         3      (1.71)p                       (2.12)p                       (3.59)p

 

 

 

 

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Statement of Financial Position as at 31 December
2023

 

                                                      Notes  31 December 2023  31 December 2022   30 June

                                                                                                  2023
                                                             Unaudited         Unaudited         Audited
                                                             £'000             £'000             £'000
 ASSETS
 Non-current assets
 Property, plant and equipment                               1                 2                 1
 Other intangible assets                                     155               126               112
 Investments                                                 382               300               382
 Total non-current assets                                    538               428               495

 Current assets
 Inventories                                                 114               45                79
 Trade and other receivables                                 37                454               202
 Cash and cash equivalents                                   176               354               436
 Total current assets                                        327               853               717

 TOTAL ASSETS                                                865               1,281             1,212

 EQUITY AND LIABILITIES
 Current liabilities
 Trade and other payables                                    542               289               500
 Borrowings                                                  39                39                39
 Total current liabilities                                   581               328               539

 Non-current liabilities
 Borrowings                                                  54                91                72
 Total non-current liabilities                               54                91                72

 EQUITY
 Equity attributable to equity holders of the parent

 Share capital                                        4      3,563             3,563             3,563
 Other reserves                                              4,018             4,014             4,018
 Retained earnings                                           (7,351)           (6,715)           (6,980)
 Total equity                                                230               862               601
 TOTAL EQUITY AND LIABILITIES                                865               1,281             1,212

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Cash Flow Statement for the period ended 31 December
2023

 

                                                                                    6 months           6 months           Year

                                                                                    to                 to                 to

                                                                                    31 December 2022   31 December 2022   30 June

                                                                                                                           2023
                                                                                    Unaudited          Unaudited          Audited
                                                                                    £'000              £'000              £'000
 Cash flows from operating activities

 Loss after taxation                                                                (371)              (437)              (702)
 Adjustments for:
 Depreciation and amortisation                                                      31                 31                 64
 Impairment loss on investments                                                     -                  -                  99
 Foreign currency reserve movement                                                  1                  5                  6
 Taxation                                                                           -                  (21)               (27)
 Finance cost                                                                       4                  3                  7
 Less movement in interest accrual                                                  -                  (2)                (1)
 Decrease / (increase) in trade and other receivables                               166                (62)               29
 Increase in inventories                                                            (35)               (4)                (39)
 Increase / (decrease) in trade and other payables                                  40                 (207)              12

 Net cash outflow from operating activities                                         (164)              (694)              (552)

 Cash flows from investing activities

 Investments acquired                                                               -                  (100)              (89)
 Purchase of intangible assets                                                      (74)               (6)                (24)
 Loan advance to associated undertaking                                             -                  -                  (37)
 Research and development corporation tax refund                                    -                  -                  27

 Net cash used in investing activities                                              (74)               (106)              (123)

 Cash flows from financing activities
 Repayment of borrowings                                                            (18)               (18)               (36)
 Interest paid                                                                      (4)                (2)                (6)
 Proceeds from share issues                                                         -                  600                600
 Share issue costs                                                                                     (20)               (20)

 Net cash (used in) / generated by financing activities                             (22)               581                538

 Net decrease in cash and cash equivalents                                          (260)              (219)              (137)
 Cash and cash equivalents at beginning of period                                   436                573                573
 Cash and cash equivalents at end of period                                         176                354                436

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Statement of Changes in Equity as at 31 December
2022

 

                                  Share capital  Share premium  Other  reserves   Retained earnings  Total equity
                                  £'000          £'000          £'000             £'000              £'000
 Balance at 1 July 2022           3,354          3,543          1                 (6,278)            620
                                  -              -              -                 (437)              (437)

 Loss for the period

 1 July 2022 to

 31 December 2022
 Share issue                      209            488            -                 -                  677
 Share issue costs                -              (20)
 Foreign exchange variance        -              -              2                 -                  2
                                  3,563          4,011          3                 (6,715)            862

 Balance at 31 December 2022

                                  -              -              -                 (265)              (265)

 Loss for the period

 1 January 2023 to 30 June 2023
 Warrants lapsed                  -              10             (10)              -                  -
 Foreign exchange variance        -              -              4                 -                  4
                                  3,563          4,021          (3)               (6,980)            601

 Balance at 30 June 2023
                                  -              -              -                 (371)              (371)

 Loss for the period

 1 July 2023 to

 31 December 2023
                                  3,563          4,021          (3)               (7,351)            230

 Balance at 31 December 2023

 

 

 

Sabien Technology Group Plc

 

Notes to the Financial Statements for the period ended 31 December 2023

 

1.            Accounting policies

 

The interim financial information has not been audited or reviewed by the
auditors and does not constitute statutory accounts for the purpose of
Sections 434 and 435 of the Companies Act 2006.

 

The financial information in this document has been prepared using accounting
principles generally accepted under International Financial Reporting
Standards and is consistent with those used in the preparation of the most
recent annual financial statements.

 

These interim financial statements for the six-month period ended 31 December
2023 have been prepared using the historical cost convention, on a going
concern basis and in accordance with applicable UK adopted International
Financial Reporting Standards.

 

The financial statements for the year ended 30 June 2023 have been delivered
to the Registrar of Companies and filed at Companies House and the auditors'
report on those financial statements was unqualified.   The auditors' report
did not contain a statement made under Section 498(2) or Section 498(3) of the
Companies Act 2006.

 

2.            Segmental reporting

 

Based on risks and returns, the directors consider that the primary reporting
business format is by business segment which is currently just the supply of
energy efficiency products, as this forms the basis of internal reports that
are regularly reviewed by the Company's chief operating decision maker in
order to allocate resources to the segment and assess its performance.
Therefore, the disclosures for the primary segment have already been given in
interim financial information. The secondary reporting format is by
geographical analysis by destination. Non-UK revenues amounted to £2k which
were less than 1% of total revenues for the period.

 

During the period, sales to the Group's largest customers were as follows:

 

             Sales revenue  % of total revenue
             £'000
 Customer 1  196            53
 Customer 2  47             13
 Customer 3  31             8
 Customer 4  18             5

 

 

 

3.            Loss per share

 

The calculation of the basic loss per share is based on the loss attributable
to the ordinary shareholders, divided by the weighted average number of shares
in issue in the period.

                                                 6 months to 31 December 2023  6 months to 31 December 2022  Year to

                                                                                                              30

                                                                                                              June

                                                                                                              2023
                                                 Unaudited                     Unaudited                     Audited
                                                 £'000                         £'000                         £'000

 Loss for the period                             (371)                         (535)                         (702)
 Basic and Diluted:
 Weighted average number of shares in issue      21,695,168                    20,532,668                    20,651,081
 Loss per share - basic and diluted              (1.71)p                       (2.12)p                       (3.59)p

 

 

4.            Share capital

 

The Company's issued Ordinary share capital is:

                                        Amount   No. of New Ordinary Shares of 3p each  No. of Deferred Shares of 4.5p each  No. of New Deferred Shares of 0.49p each

                                        £'000

 Allotted, called up and fully paid:
 At 31 December 2023                    3,563    21,695,168                             44,004,867                           190,254,867
 At 30 June 2023                        3,363    21,695,168                             44,004,867                           190,254,867
 At 31 December 2022                    3,563    21,695,168                             44,004,867                           190,254,867

 

 

 

5.            Share options and warrants

 

At the period end date, the following options had been granted:

 

 Grant date       Number of instruments  Exercise price  Contractual life of instruments

 31 October 2014  117                    £163.5          October 2024

 

At the period end date, there were no warrants outstanding (31 December 2022:
1,675,349, 30 June 2023: nil).

 

In February 2023, 1,675,349 outstanding warrants expired.

 

6.            Seasonality

 

The business of the Group is not seasonal.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR DKLBFZLLLBBD

Recent news on Sabien Technology

See all news